A BioMarker Driven Protocol for Previously Treated ALK-Positive NonSquamous NonSmall Cell Lung Cancer (LU003)
A BioMarker Driven Protocol for Previously Treated ALK-Positive NonSquamous NonSmall Cell Lung Cancer (LU003)
Trial Category:
Lung
Contact(s)
Location(s)
Methodist Estabrook Cancer Center, Omaha, NE